Description
Micronisation decreases the particle size (<5 micron), which increases dissolution Coating the progesterone with lipids increases its bioavailability Oral administration ensures rapid and adequate progesterone concentrations in the blood increases ongoing and clinical pregnancy rates and reduces the rate of abortions
- Luteal Phase Defect
- Secondary Amenorrhea
- Following Ovulation induction
- Threatened and Recurrent Abortion
